Ponatinib reduces viability, migration, and functionality of human endothelial cells.
Gover-Proaktor A, Granot G, Shapira S, Raz O, Pasvolsky O, Nagler A, Lev DL, Inbal A, Lubin I, Raanani P, Leader A.
Gover-Proaktor A, et al. Among authors: leader a.
Leuk Lymphoma. 2017 Jun;58(6):1455-1467. doi: 10.1080/10428194.2016.1239258. Epub 2016 Oct 12.
Leuk Lymphoma. 2017.
PMID: 27733071